Clinical Trial Update: Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis [Phase 3]

View source ↗

Summary

A Phase 3 trial investigated whether trimethoprim-sulfamethoxazole reduces recurrence of ocular toxoplasmosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Toxoplasmosis

Drugs mentioned

• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Ocular Toxoplasmosis | Phase 3 | Status: COMPLETED